Women's Health

Tirzepatide is a dual agonist, meaning it activates two hormones—GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide)—which help regulate blood sugar levels and promote weight loss. Tirzepatide has also shown significant potential in clinical trials for improving glycemic control and aiding in weight reduction, leading to its growing use in managing obesity and diabetes

How does Tirzepatide work? 

Tirzepatide has shown significant potential for weight loss by targeting both GIP and GLP-1 receptors, which help regulate appetite and fat storage. Clinical trials have demonstrated that it can lead to substantial reductions in body weight, making it a promising option for those struggling with obesity.